Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: Epidemiological evaluation results

Infectious Diseases of Poverty

Volumn 5, Issue 1, 2016, Pages

  Tekle, Afework H ^a   Zouré, Honorath G M ^a   Noma, Mounkaila ^a   Boussinesq, Michel ^b   Coffeng, Luc E ^c   Stolk, Wilma A ^c   Remme, Jan H F ^d  

^a Ouagadougou University   (Burkina Faso)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d NONE   (France)

Author keywords

APOC; Community directed treatment; Elimination; Ivermectin; Onchocerciasis; ONCHOSIM

Indexed keywords

IVERMECTIN; ANTIFILARIAL AGENT;

ADULT; AFRICAN; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DISEASE ELIMINATION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PATHOGEN LOAD; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; SKIN BIOPSY; AFRICA SOUTH OF THE SAHARA; ANIMAL; BAYES THEOREM; COMMUNITY CARE; DRUG EFFECTS; MICROFILARIA (NEMATODE LARVA); MONTE CARLO METHOD; PARASITOLOGY; PREVALENCE;

AFRICA SOUTH OF THE SAHARA; ANIMALS; BAYES THEOREM; COMMUNITY HEALTH SERVICES; FILARICIDES; IVERMECTIN; MICROFILARIAE; MONTE CARLO METHOD; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PREVALENCE;

EID: 85006198774     PISSN: 20955162     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/s40249-016-0160-7     Document Type: Article

References (61)

1. World Health Organization. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. Geneva: World Health Organization; 1995. p. 1-104. http://apps.who.int/iris/bitstream/10665/37346/1/WHO_TRS_852.pdf.
2. Kim YE, Remme JH, Steinmann P, Stolk WA, Roungou JB, Tediosi F. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa. PLoS Negl Trop Dis. 2015;9(4):e0003664.
3. Zoure HG, Noma M, Tekle AH, Amazigo UV, Diggle PJ, Giorgi E, Remme JH. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected. Parasit Vectors. 2014;7:326.
4. O'Hanlon SJ, Slater HC, Cheke RA, Boatin BA, Coffeng LE, Pion SD, Boussinesq M, Zoure HG, Stolk WA, Basanez MG. Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa. PLoS Negl Trop Dis. 2016;10(1):e0004328.
5. Amazigo U. The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol. 2008;102 Suppl 1:19-22.
6. Boatin B. The Onchocerciasis Control Programme in West Africa (OCP). Ann Trop Med Parasitol. 2008;102 Suppl 1:13-7.
7. Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF, Okello D, Ozoh G, Remme J. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol. 2002;96(3):283-96.
8. Kaiser C, Pion SD, Boussinesq M. Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(3):e2147.
9. Walker M, Little MP, Wagner KS, Soumbey-Alley EW, Boatin BA, Basanez MG. Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality. PLoS Negl Trop Dis. 2012;6(3):e1578.
10. Korevaar DA, Visser BJ. Reviewing the evidence on nodding syndrome, a mysterious tropical disorder. Int J Infect Dis. 2013;17(3):e149-52.
11. Dunn C, Callahan K, Katabarwa M, Richards F, Hopkins D, Withers PC, Jr., Buyon LE, McFarland D. The contributions of onchocerciasis control and elimination programs toward the achievement of the millennium development goals. PLoS Negl Trop Dis. 2015;9(5):e0003703.
12. Thylefors B. The Mectizan Donation Program (MDP). Ann Trop Med Parasitol. 2008;102 Suppl 1:39-44.
13. Boatin BA. The current state of the Onchocerciasis Control Programme in West Africa. Trop Doct. 2003;33(4):209-14.
14. Basanez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(5):310-22.
15. Tielsch JM, Beeche A. Impact of ivermectin on illness and disability associated with onchocerciasis. Trop Med Int Health. 2004;9(4):A45-56.
16. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Community-directed treatment with ivermectin: report of a multi-country study. TDR/AFT/RP/96.1. Geneva: World Health Organization; 1996. http://www.who.int/tdr/publications/documents/comdti_1.pdf.
17. Amazigo U, Okeibunor J, Matovu V, Zoure H, Bump J, Seketeli A. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med. 2007;64(10):2070-82.
18. Remme JHF. The Global Burden of Onchocerciasis in 1990. Geneva: World Health Organization; 2004. http://www.who.int/healthinfo/global_burden_disease/Onchocerciasis%201990.pdf.
19. African Programme for Onchocerciasis Control: progress report, 2014-2015. Wkly Epidemiol Rec 2015, 90(49):661-674
20. Coffeng LE, Stolk WA, Zoure HG, Veerman JL, Agblewonu KB, Murdoch ME, Noma M, Fobi G, Richardus JH, Bundy DA, Habbema D, de Vlas SJ, Amazigo UV. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost. PLoS Negl Trop Dis. 2013;7(1):e2032.
21. Dadzie Y, Neira M, Hopkins D. Final report of the conference on the eradicability of onchocerciasis. Filaria J. 2003;2(1):2.
22. Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW, Bissan Y, Renz A, Yameogo L, Remme JH, Habbema JD. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J. 2003;2(1):8.
23. Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF, Toe L, Touree S, Remme JH. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in mali and senegal. PLoS Negl Trop Dis. 2009;3(7):e497.
24. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, Goita SF, Konate L, Mounkoro K, Seck AF, Toe L, Toure S, Remme JH. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6(9):e1825.
25. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors. 2012;5:28.
26. World Health Organization. Informal consultation on elimination of onchocerciasis transmission with current tools in Africa - "shrinking the map". Ouagadougou: African Programme for Onchocerciasis Control; 2009. http://www.mectizan.org/sites/www.mectizan.org/files/attachments/resources/Report%20of%20Informal%20consultation%20on%20elimination%20of%20oncho%20transmission%20with%20current%20tools%20in%20Africa.pdf.
27. World Health Organization. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. Ouagadougou: African Programme for Onchocerciasis Control; 2010. http://www.who.int/apoc/oncho_elimination_report_english.pdf.
28. Remme J, Ba O, Dadzie KY, Karam M. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ. 1986;64(5):667-81.
29. Stolk WA, Walker M, Coffeng LE, Basanez MG, de Vlas SJ. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors. 2015;8(1):552.
30. Duerr HP, Raddatz G, Eichner M. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol. 2011;41(5):581-9.
31. Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ. 1998;76 Suppl 2:22-5.
32. Prost A, Prod'hon J. [Parasitological diagnosis of onchocerciasis. A critical review of present methods (author's transl)]. Med Trop Mars. 1978;38:519-32.
33. Plaisier AP, van Oortmarssen GJ, Habbema JD, Remme J, Alley ES. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed. 1990;31(1):43-56.
34. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van Oortmarssen G, Boatin BA, Habbema JD. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ. 2002;80(5):384-91.
35. Plaisier AP, van Oortmarssen GJ, Remme J, Alley ES, Habbema JD. The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bull World Health Organ. 1991;69(2):169-78.
36. Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, de Vlas SJ. Elimination of african onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. PLoS ONE. 2014;9(12):e115886.
37. Habbema JD, Plaisier AP, van Oortmarssen GJ, Remme J. Prospective evaluation of onchocerciasis control strategies. Acta Leiden. 1990;59(1-2):387-98.
38. Remme J, De Sole G, van Oortmarssen GJ. The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simulium spp. in west Africa. Bull World Health Organ. 1990;68(3):331-9.
39. Remme JHF. Research for control: the example of onchocerciasis. Trop Med Int Health. 2004;9(2):243-54.
40. Hougard JM, Alley ES, Yameogo L, Dadzie KY, Boatin BA. Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J Infect Dis. 2001;184(4):497-503.
41. Coffeng LE, Pion SD, O'Hanlon S, Cousens S, Abiose AO, Fischer PU, Remme JH, Dadzie KY, Murdoch ME, de Vlas SJ, Basanez MG, Stolk WA, Boussinesq M. Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis. 2013;7(4):e2168.
42. Bolstad WM. Introduction to Bayesian statistics. New Jersey: John Wiley & Sons; 2013
43. Agoua H, Alley ES, Hougard JM, Akpoboua KL, Boatin B, Seketeli A. Etudes entomologiques de post-traitement dans le Programme de Lutte contre l'Onchocercose en Afrique de l'Ouest. Parasite. 1995;2:281-8.
44. Remme JHF, Alley ES, Plaisier AP. Estimation and prediction in tropical disease control: the example of onchocerciasis. In: Mollison D, editor. Epidemic models: their structure and relation to data. Cambridge: Cambridge University Press; 1995. p. 372-92.
45. Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum NK, Hopkins A, Prichard RK, Basanez MG. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis. 2014;59(7):923-32.
46. Prost A, Thylefors B, Pairault C: Methods of mass epidemiological evaluation of onchocerciasis. Their utilization in a vector control programme. Geneva: World Health Organization; 1975
47. Boussinesq M, Prodqhon J, Chippaux J. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments. Trans R Soc Trop Med Hyg. 1997;91(1):82-6.
48. Dadzie KY, Remme J, De Sole G, Boatin B, Alley ES, Ba O, Samba EM. Onchocerciasis control by large-scale ivermectin treatment. Lancet. 1991;337(8753):1358-9.
49. Higazi TB, Zarroug IM, Mohamed HA, Mohamed WA, Deran TC, Aziz N, Katabarwa M, Hassan HK, Unnasch TR, Mackenzie CD, Richards F. Polymerase chain reaction pool screening used to compare prevalence of infective black flies in two onchocerciasis foci in northern Sudan. Am J Trop Med Hyg. 2011;84(5):753-6.
50. Eisenbarth A, Achukwi MD, Renz A. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon. PLoS Negl Trop Dis. 2016;10(2):e0004392.
51. World Health Organization. Report of the consultative meetings on strategic options and alternative treatment strategies for accelerating onchocerciasis elimination in Africa. Ouagadougou: African Programme for Onchocerciasis Control; 2015. http://www.who.int/apoc/ATS_Report_2015.12.pdf.
52. Awadzi K, Opoku NO, Attah SK, Lazdins-Helds JK, Kuesel AC. Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch. Parasit Vectors. 2015;8:515.
53. Hoerauf A, Specht S, Buttner M, Pfarr K, Mand S, Fimmers R, Marfo-Debrekyei Y, Konadu P, Debrah AY, Bandi C, Brattig N, Albers A, Larbi J, Batsa L, Taylor MJ, Adjei O, Buttner DW. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol. 2008;197(3):295-311.
54. Thompson BH. Studies on the flight range and dispersal of Simulium damnosum (Diptera: Simuliidae) in the rain-forest of Cameroon. Ann Trop Med Parasitol. 1976;70:343-54.
55. World Health Organisation. Certification of elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization; 2001. p. 64. http://apps.who.int/iris/bitstream/10665/66889/1/WHO_CDS_CPE_CEE_2001.18b.pdf.
56. World Health Organisation: Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures. World Health Organisation; 2016; http://apps.who.int/iris/bitstream/10665/204180/1/9789241510011_eng.pdf.
57. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol. 2008;102 Suppl 1:25-9.
58. Centers for Disease Control and Prevention. Progress toward elimination of onchocerciasis in the Americas - 1993-2012. MMWR Morb Mortal Wkly Rep. 2013;62(20):405-8.
59. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec 2013, 88(36):381-385.
60. Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico. Wkly Epidemiol Rec 2015, 90(43):577-581.
61. The African Programme for Onchocerciasis Control (APOC) closes and a new body set up to eliminate Neglected Tropical Diseases [ http://www.afro.who.int/en/media-centre/pressreleases/item/8239 ] Accessed 23 Jun 2016